Association of MeCP2 (rs2075596, rs2239464) genetic polymorphisms with systemic lupus erythematosus: A meta-analysis

Lupus

Volumn 22, Issue 9, 2013, Pages 908-918

  Liu, K ^a   Zhang, L ^b   Chen, J ^b   Hu, Z ^b   Cai, G ^b   Hong, Q ^b  

^a NINGBO UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

MeCP2; meta analysis; Methyl CpG binding protein 2; polymorphism; SLE; systemic lupus erythematosus

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ALLELE; ARTICLE; DISEASE ASSOCIATION; DNA METHYLATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HISTONE MODIFICATION; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MUTATION; RISK FACTOR; STATISTICAL MODEL;

GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYL-CPG-BINDING PROTEIN 2; MODELS, STATISTICAL; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84880894166     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313496340     Document Type: Article

References (48)

1. Hochberg MC. Systemic lupus erythematosus. Rheum Dis Clin North Am. 1990 ; 16: 617-639
2. El-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus. Circulation. 2004 ; 110: 399-404
3. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011 ; 365: 2110-2121
4. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
6. Osio-Salido E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus. 2010 ; 19: 1365-1373
7. Mok C. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus. 2011 ; 20: 767-771
8. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 2001 ; 15: 397-408
9. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev. 2010 ; 9: 277-287
10. Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: Prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken). 2012 ; 64: 159-168
11. Keshet I, Lieman-Hurwitz J, Cedar H. DNA methylation affects the formation of active chromatin. Cell. 1986 ; 44: 535-543
12. Bhakat KK, Mitra S. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. Carcinogenesis. 2003 ; 24: 1337-1345
13. Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997 ; 88: 471-481
14. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998 ; 19: 187-191
15. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998 ; 393: 386-389
16. Sekigawa I, Okada M, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. DNA methylation in systemic lupus erythematosus. Lupus. 2003 ; 12: 79-85
17. Sekigawa I, Kawasaki M, Ogasawara H, et al. DNA methylation: Its contribution to systemic lupus erythematosus. Clin Exp Med. 2006 ; 6: 99-106
18. Sawalha AH, Webb R, Han S, et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One. 2008 ; 3: e1727 - e1727
19. Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008 ; 320: 1224-1229
20. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2005 ; 33: 1665-1673
21. Javierre BM, Fernandez AF, Richter J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010 ; 20: 170-179
22. Wen Z, Xu W, Xu L, et al. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford). 2007 ; 46: 1796-1803
23. Lei W, Luo Y, Yan K, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol. 2009 ; 38: 369-374
24. Ren J, Peng C, Chen S, et al. Association of methyl-CpG-binding protein 2 (MeCP2) polymorphisms with systemic lupus erythematosus (SLE) among Chinese Han population in south of the Yangtze River. Fudan University Journal of Medical Sciences. 2012 ; 39: 146-151
25. Kaufman KM, Zhao J, Kelly JA, et al. Fine mapping of Xq28: Both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis. 2013 ; 72: 437-444
26. Hunter JE, Schmidt FL, Jackson GB Meta-analysis: Cumulating research findings across studies. Beverly Hills, CA: SAGE Publications, Inc ; 1982:
27. Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 ; 21: 1539-1558
28. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?. Psychol Methods. 2006 ; 11: 193-206
29. Hedges LV, Vevea JL. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998 ; 3: 486-504
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 ; 50: 1088-1101
31. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 ; 315: 629-634
32. Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 ; 327: 557-560
33. Tiffin N, Adeyemo A, Okpechi I. A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis. 2013 ; 8: 1-8
34. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008 ; 358: 929-939
35. Namjou B, Kothari PH, Kelly JA, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 2011 ; 12: 270-279
36. Munoz L, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus. 2008 ; 17: 371-375
37. Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun. 2013 ; 41: 92-99
38. Zhou Y, Qiu X, Luo Y, et al. Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells. Lupus. 2011 ; 20: 1365-1371
39. Attwood J, Yung R, Richardson B. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 2002 ; 59: 241-257
40. Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005 ; 6: 597-610
41. Luo Y, Li Y, Su Y, et al. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol. 2008 ; 159: 827-833
42. Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med. 2009 ; 360: 1759-1768
43. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996 ; 273: 1516-1517
44. Lei W, Luo Y, Lei W, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol. 2009 ; 38: 369-374
45. Oelke K, Lu Q, Richardson D, et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 2004 ; 50: 1850-1860
46. Deng C, Kaplan MJ, Yang J, et al. Decreased ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 2001 ; 44: 397-407
47. Sestak AL, Fürnrohr BG, Harley JB, Merrill JT, Namjou B. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis. 2011 ; 70: i37 - i43
48. Webb R, Wren JD, Jeffries M, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis & Rheumatism 2009; 60: 1076-1084.